Log In
BCIQ
Print this Print this
 

Hexacima, Hexyon (Hexaxim) (DTP-HepB-Polio-Hib Pediatric hexavalent vaccine)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionCombination vaccine against diphtheria, tetanus and pertussis (DTP), hepatitis B, polio and Haemophilus influenzae type b (Hib)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentApproved
Standard IndicationBacterial infection
Indication DetailsVaccinate against DTP, tetanus, pertussis, hepatitis B, polio and Haemophilus influenzae type B
Regulatory Designation
PartnerSanofi

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today